Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage

Sebastian Thaler*, Michal Fiedorowicz, Tomasz J. Choragiewicz, Sylvia Bolz, Ayseguel Tura, Sigrid Henke-Fahle, Efdal Yoeruek, Eberhart Zrenner, Karl Ulrich Bartz-Schmidt, Focke Ziemssen, Frank Schuettauf

*Korrespondierende/r Autor/-in für diese Arbeit
33 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage“. Zusammen bilden sie einen einzigartigen Fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science